Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Budget 2016:Health Ministry asks for Excessive Taxation on Tobacco Products

      Budget 2016:Health Ministry asks for Excessive Taxation on Tobacco Products

      savita thakur thakur29 Feb 2016 11:39 AM IST
      New Delhi: The Health Ministry is seeking excessive taxation on tobacco products in the up coming budget for the year 2016. Its demand is based on a...
      Tax group blasts Pfizer, urges stop to its tax-cutting deal

      Tax group blasts Pfizer, urges stop to its tax-cutting deal

      savita thakur thakur27 Feb 2016 4:00 PM IST
      A consumer group is accusing Pfizer of seeking to avoid $35 billion in U.S. taxes with its plan to buy fellow drugmaker Allergan in a deal structured...
      US jury awards USD 72 million in Johnson & Johnson cancer suit

      US jury awards USD 72 million in Johnson & Johnson cancer suit

      savita thakur thakur26 Feb 2016 3:18 PM IST
      St Louis: A jury in the US state of Missouri has awarded USD 72 million to the family of an Alabama woman who died from ovarian cancer, which she said...
      Drug price regulator finds 4,700 medicines illegally over-priced

      Drug price regulator finds 4,700 medicines illegally over-priced

      savita thakur thakur26 Feb 2016 1:36 PM IST
      New Delhi: The national drug price regulator NPPA has warned of action against companies violating its pricing norms as it found prices of more than...
      Drug distributor McKesson to buy two cancer care firms for $1.2 bln

      Drug distributor McKesson to buy two cancer care firms for $1.2 bln

      savita thakur thakur26 Feb 2016 12:43 PM IST
      Drug distributor McKesson Corp said it was buying two privately held cancer care service providers, Vantage Oncology LLC and Biologics Inc, for a...
      AstraZeneca

      AstraZeneca's $4 billion Acerta deal endorsed by orphan drug status

      savita thakur thakur26 Feb 2016 12:40 PM IST
      London: AstraZeneca's bold move to buy 55 percent of privately held biotech firm Acerta Pharma for $4 billion in December has been vindicated, at...
      Glenmark Pharmaceuticals starts studies on new drug aimed at cancer treatment

      Glenmark Pharmaceuticals starts studies on new drug aimed at cancer treatment

      savita thakur thakur25 Feb 2016 4:24 PM IST
      New Delhi: Glenmark Pharmaceuticals announced discovery and initiation of enabling studies of an investigational new drug (IND) molecule targeted at...
      U.S. and EU regulators urge Indian drug companies to step up standards

      U.S. and EU regulators urge Indian drug companies to step up standards

      savita thakur thakur25 Feb 2016 2:59 PM IST
      U.S. and EU drug regulators called upon Indian drug companies to step up efforts to improve manufacturing standards and ensure the reliability of data...
      Cipla launches generic hepatitis C drug Hepcvir-L in India

      Cipla launches generic hepatitis C drug Hepcvir-L in India

      savita thakur thakur25 Feb 2016 2:00 PM IST
      New Delhi: Drug major Cipla has launched generic tablets used for treating of hepatitis C under the brand name 'Hepcvir-L' costing Rs 25,000 for a...
      Glenmark gets USFDA nod for contraceptive tablets

      Glenmark gets USFDA nod for contraceptive tablets

      savita thakur thakur25 Feb 2016 1:13 PM IST
      New Delhi: Glenmark Pharmaceuticals has received the final nod from the US health regulator for generic oral contraceptive norgestimate ethinyl...
      Ministry redrafts national policy for drug demand reduction

      Ministry redrafts national policy for drug demand reduction

      savita thakur thakur24 Feb 2016 4:26 PM IST
      New Delhi: The national policy for drug demand reduction, which seeks to address the problem of drug and substance abuse in the country was redrafted...
      Fast acting anti-rabies drug set for an India launch

      Fast acting anti-rabies drug set for an India launch

      savita thakur thakur24 Feb 2016 1:27 PM IST
      An instantly activated drug, in other words a fast acting anti-rabies drug to rapidly deactivate the rabies virus is soon to be launched in India. It...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok